Support documents for Study Participants
COVID-19 Critical Care Consortium Sub-Studies
-
Acute Kidney Injury
The COVID-Critical study is an excellent opportunity to determine the incidence and severity of COVID-induced AKI, the impact of renal dysfunction severity, critical care management (e.g. mechanical ventilation, fluids, nephrotoxic drugs), the extent of recovery of renal function, and outcomes from COVID-19 critical illness.
-
Coagulation Disorders
This subgroup will focus on physiologic changes in COVID patients related to hemostasis and how these factors are associated with bleeding and thrombotic complications in COVID 19 patients.
-
Neurological
Specific research area includes neuroimaging, brain autopsy, biomarkers, and cognitive outcomes.
-
Cardiac
Data will be collected retrospectively on cardiac comorbidities, cardiac complications during the hospital admission for COVID-19.
-
![]()
COVID Critical meeting at EuroELSO
After years collaborating remotely via Zoom and emails alone, members of the COVID-19 Critical Care Consortium (COVID Critical) came together in London recently for a once in a lifetime celebration.
-
![]()
What does the Consortium mean to our global community
Established in 2020, the COVID-19 Critical Care Consortium was created to support ICUs at the coal face of the pandemic. The Australian-led initiative quickly became so much more.
-
![]()
In the news
A dedicated team at Brisbane's Prince Charles Hospital has collected COVID health data on critically ill patients across the globe. December 2021.
-
![]()
EuroELSO Young Investigator Award
Congratulations are in order for the Critical Care Research Group’s Dr Silver Heinsar who has been named as one of twelve ELSO Young Investigators for 2022.
-
![]()
COVID Critical Frequently Asked Questions
What is the association between ISARIC, SPRINT-SARI and the COVID-19 Critical Care Consortium Incorporating the ECMOCARD (COVID Critical) Study?
-
![]()
CRIKEY 2023
World leaders in intensive care and research came together in Australia for a meeting of minds at the inaugural Critical care Research International: Knowledge, Evidence and beYond (CRIKEY) Summit.
-
![]()
Dr Martin Urner presents the Consortium's VV ECMO study
Life-support system reduced COVID-19 mortality by 7.1%, study shows - An international observational study published in the British Medical Journal showed ECMO has a significant impact in saving lives of the sickest COVID-19 patients.
